Showing 13,181 - 13,190 of 13,355
The aim of this paper is to analyze the impact of the deregulation of the Norwegian pharmaceuticals market in 2001 on … pharmacies have not decreased as a consequence of the deregulation of the Norwegian pharmaceuticals market. The deregulation of …
Persistent link: https://www.econbiz.de/10005419304
In a double marginalization model which is played between a domestic monopolistic manufacturer of pharmaceuticals and a …
Persistent link: https://www.econbiz.de/10005751246
In Spain, the social security (i.e., the public health system) budget relays on the local administrations of every region. From this budget, a very important amount of money goes to finance, totally or partially and medicines for people. If the administrations do not take this issue seriously,...
Persistent link: https://www.econbiz.de/10005753536
, and the activities of Shaman Pharmaceuticals in Latin America and Africa. It provides the details, discusses what each …
Persistent link: https://www.econbiz.de/10005621738
Globalization, far from eliminating the relevance of geography, brings to the surface the importance of location as a collector and repository of specialized knowledge. In this “new age of capitalism”, regions are emerging as important catalysts for innovation and production development....
Persistent link: https://www.econbiz.de/10005636114
We study the choice of drug for the treatment of high blood pressure (hypertension) in Sweden between 1988-1994. During this time period calcium antagonists and ACE-inhibitors increased their market shares at the expense of the older drugs diuretics and beta-blockers. We use a prescription micro...
Persistent link: https://www.econbiz.de/10005651525
and quantities of pharmaceuticals prescribed by physicians working at these health centres differ significantly from those …
Persistent link: https://www.econbiz.de/10005652033
We study effects of direct-to-consumer advertising (DTCA) in a mar- ket with two pharmaceutical firms providing horizontally dierentiated (branded) drugs. Patients varying in their susceptability to medication are a prioriuninformed of available medication. Physicians making the prescription...
Persistent link: https://www.econbiz.de/10005695847
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
The Committee’s present examination of ‘Availability and Price Management of Drugs and Pharmaceuticals’ is with the objective of making available quality medicines at affordable prices to the masses. The Committee desire that their recommendations are considered in the...
Persistent link: https://www.econbiz.de/10005696028